Zafgen Inc (NASDAQ:ZFGN) Sellers Rose By 13.18% Their Shorts

June 29, 2018 - By Jane Lemasters

Zafgen, Inc. (NASDAQ:ZFGN) Corporate Logo

Change of 13.18% for Zafgen Inc (NASDAQ:ZFGN)’s short interest was reported. In June was published ZFGN’s total 677,600 short interest by FINRA. The 598,700 previous shares are up with 13.18%. Zafgen Inc (NASDAQ:ZFGN) has 171,500 shares average volume. It’ll cost 4 days for ZFGN to recover its previous position. Zafgen Inc’s short interest float is 3.01%.

ZFGN touched $9.98 during the last trading session after $0.38 change.Zafgen, Inc. has 539,372 shares volume, 114.87% up from normal. ZFGN is uptrending and has moved 60.78% since June 29, 2017. ZFGN outperformed the S&P500 by 48.21%.

Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from metabolic diseases comprising type 2 diabetes and obesity.The firm is valued at $275.08 million. The companyÂ’s lead product candidate is ZGN-1061, a fumagillin-class MetAP2 inhibitor administered by subcutaneous injection, which is in Phase 1 clinical trial and profiled for its utility in the treatment of metabolic diseases.Last it reported negative earnings.

Zafgen, Inc. (NASDAQ:ZFGN) Ratings Coverage

A total of 2 analysts rate Zafgen (NASDAQ:ZFGN) as follows: 1 “Buy”, 1 “Hold” and 0 “Sell”. Тherefore 50% are bullish. (NASDAQ:ZFGN) has 2 ratings reports on Jun 29, 2018 according to StockzIntelligence.

For more Zafgen, Inc. (NASDAQ:ZFGN) news announced recently go to: Benzinga.com, Nasdaq.com, Benzinga.com, Nasdaq.com or Globenewswire.com. The titles are as follows: “48 Biggest Movers From Yesterday” announced on June 29, 2018, “Mid-Afternoon Market Update: NASDAQ Down Over 2.5%; Xerium Technologies Shares Spike Higher” on June 25, 2018, “Benzinga’s Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut” with a publish date: June 28, 2018, “Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to …” and the last “Zafgen Announces Pricing of Offering of Common Stock” with publication date: June 28, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: